Robert Andrew Douglas - Net Worth and Insider Trading

Robert Andrew Douglas Net Worth

The estimated net worth of Robert Andrew Douglas is at least $58 Million dollars as of 2024-04-27. Robert Andrew Douglas is the President and COO of ResMed Inc and owns about 267,400 shares of ResMed Inc (RMD) stock worth over $58 Million. Robert Andrew Douglas is also the Director of Globus Medical Inc and owns about 2,005 shares of Globus Medical Inc (GMED) stock worth over $101,353. Details can be seen in Robert Andrew Douglas's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert Andrew Douglas has not made any transactions after 2023-08-15 and currently still holds the listed stock(s).

Transaction Summary of Robert Andrew Douglas

To

Robert Andrew Douglas Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Andrew Douglas owns 2 companies in total, including ResMed Inc (RMD) , and Globus Medical Inc (GMED) .

Click here to see the complete history of Robert Andrew Douglas’s form 4 insider trades.

Insider Ownership Summary of Robert Andrew Douglas

Ticker Comapny Transaction Date Type of Owner
RMD ResMed Inc 2023-08-15 President and COO
GMED Globus Medical Inc 2020-08-24 director

Robert Andrew Douglas Latest Holdings Summary

Robert Andrew Douglas currently owns a total of 2 stocks. Among these stocks, Robert Andrew Douglas owns 267,400 shares of ResMed Inc (RMD) as of August 15, 2023, with a value of $58 Million and a weighting of 99.83%. Robert Andrew Douglas also owns 2,005 shares of Globus Medical Inc (GMED) as of August 24, 2020, with a value of $101,353 and a weighting of 0.17%.

Latest Holdings of Robert Andrew Douglas

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RMD ResMed Inc 2023-08-15 267,400 218.06 58,309,244
GMED Globus Medical Inc 2020-08-24 2,005 50.55 101,353

Holding Weightings of Robert Andrew Douglas


Robert Andrew Douglas Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert Andrew Douglas has made a total of 46 transactions in ResMed Inc (RMD) over the past 5 years, including 0 buys and 46 sells. The most-recent trade in ResMed Inc is the sale of 1,500 shares on August 15, 2023, which brought Robert Andrew Douglas around $271,515.

According to the SEC Form 4 filings, Robert Andrew Douglas has made a total of 3 transactions in Globus Medical Inc (GMED) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Globus Medical Inc is the acquisition of 615 shares on August 24, 2020, which cost Robert Andrew Douglas around $33,136.

Insider Trading History of Robert Andrew Douglas

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert Andrew Douglas Trading Performance

GuruFocus tracks the stock performance after each of Robert Andrew Douglas's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert Andrew Douglas is 9.43%. GuruFocus also compares Robert Andrew Douglas's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert Andrew Douglas within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert Andrew Douglas's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert Andrew Douglas

Average Return

57.05%

Average return per transaction

Outperforming Transactions

100%

3 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.77 9.43 30.4 57.05 8.37 5.23
Relative Return to S&P 500(%) -0.36 3.53 13.76 23.62 -1.5 -5.41

Robert Andrew Douglas Ownership Network

Ownership Network List of Robert Andrew Douglas

No Data

Ownership Network Relation of Robert Andrew Douglas


Robert Andrew Douglas Owned Company Details

What does ResMed Inc do?

Who are the key executives at ResMed Inc?

Robert Andrew Douglas is the President and COO of ResMed Inc. Other key executives at ResMed Inc include Global General Counsel Michael J Rider , Chief Financial Officer Brett Sandercock , and Chief Executive Officer Michael J. Farrell .

ResMed Inc (RMD) Insider Trades Summary

Over the past 18 months, Robert Andrew Douglas made 9 insider transaction in ResMed Inc (RMD) with a net sale of 23,280. Other recent insider transactions involving ResMed Inc (RMD) include a net sale of 72,983 shares made by Michael J. Farrell , a net sale of 37,000 shares made by Brett Sandercock , and a net sale of 9,045 shares made by David Pendarvis .

In summary, during the past 3 months, insiders sold 23,816 shares of ResMed Inc (RMD) in total and bought 0 shares, with a net sale of 23,816 shares. During the past 18 months, 183,814 shares of ResMed Inc (RMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 183,814 shares.

ResMed Inc (RMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ResMed Inc Insider Transactions

No Available Data

Robert Andrew Douglas Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Andrew Douglas. You might contact Robert Andrew Douglas via mailing address: 21 Attunga Road, Newport, New South Wales C3 2106.

Discussions on Robert Andrew Douglas

No discussions yet.